ClinConnect ClinConnect Logo
Search / Trial NCT06783075

Milk Vs Wheat Protein Intake to Maximize Whole-body Protein Synthesis Rates in Healthy Older Adults

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Jan 14, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Whole Body Protein Synthesis

ClinConnect Summary

This clinical trial is studying how different types of protein can affect the body’s ability to use protein effectively, especially in healthy older adults. The researchers want to compare the effects of milk protein, which is high quality, to wheat protein, which is a plant-based option that might not be as effective for protein synthesis. The goal is to understand if the quality of protein matters for older adults who are trying to maintain their health and muscle strength.

To participate in this trial, you need to be between 65 and 85 years old and have a body mass index (BMI) between 18.5 and 30. You should be generally healthy and engage in light exercise, but not intense workouts more than once a week. If you smoke, have certain health conditions, or take specific medications that affect protein metabolism, you may not be eligible. Participants will be asked to follow a diet that includes either milk or wheat protein, and they can expect to contribute to important research that could help improve dietary recommendations for older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged between 65-85 years
  • BMI between 18.5-30 kg\*m\^-2
  • Healthy, recreationally active (maximal one intensive exercise training per week)
  • No physical limitations (i.e., able to perform all activities associated with daily living independently)
  • Exclusion Criteria:
  • Smoking
  • Diagnosed musculoskeletal disorders
  • Use of any medications known to affect protein metabolism (i.e., corticosteriods, non-steroidal anti-inflammatories)
  • Chronic use of gastic acid-suppressing medication or anti-coagulants
  • Unstable weight over the last 3 months
  • Diagnosed GI tract disorders or diseases
  • Blood donation in the past 2 months

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, Limburg, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported